Alkyl Amines Chemicals Limited
Alkyl Amines Chemicals Limited (ALKYLAMINE) financial statements and selected valuation metrics from NSE/BSE exchange filings through 30 June 2026.
Commodities›Chemicals›Chemicals & Petrochemicals›Specialty Chemicals
alkylamines.com(opens the company website in a new tab)Key metrics
Price as of 2026-09-03
Sign in for full ratios and TTM. Learn about these metrics →
Share price
NSE closing price from historical market data.
Loading price history…
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Mar 2019BSE balance sheet (this exchange's own filing had none for this period) | Sept 2019BSE balance sheet (this exchange's own filing had none for this period) | Dec 2019 | Mar 2020BSE balance sheet (this exchange's own filing had none for this period) | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Sales | 237 Cr | 235 Cr | 257 Cr | 235 Cr | 386 Cr | 406 Cr | 389 Cr | 354 Cr |
| Operating expenses (approx.) | 199 Cr | 177 Cr | 184 Cr | 167 Cr | 318 Cr | 329 Cr | 319 Cr | 287 Cr |
| EBITDA | 38 Cr | 58 Cr | 73 Cr | 68 Cr | 68 Cr | 77 Cr | 70 Cr | 67 Cr |
| OPM % | 16.2% | 24.6% | 28.2% | 28.8% | 17.6% | 18.9% | 18.0% | 19.0% |
| Other income | 2 Cr | 0.30 Cr | 2 Cr | 3 Cr | 9 Cr | 8 Cr | 7 Cr | 8 Cr |
| Interest | 3 Cr | 3 Cr | 2 Cr | 2 Cr | 0.17 Cr | 0.30 Cr | 0.34 Cr | 0.24 Cr |
| Depreciation | 6 Cr | 7 Cr | 7 Cr | 7 Cr | 18 Cr | 18 Cr | 18 Cr | 18 Cr |
| Profit before tax | 30 Cr | 51 Cr | 82 Cr | 61 Cr | 59 Cr | 66 Cr | 59 Cr | 57 Cr |
| Tax % | 41.9% | -8.7% | 26.3% | 19.5% | 22.5% | 25.5% | 27.4% | 26.2% |
| Net profit | 18 Cr | 55 Cr | 60 Cr | 49 Cr | 46 Cr | 49 Cr | 43 Cr | 42 Cr |
| EPS (₹) | ₹8.61 | ₹26.93 | ₹29.62 | ₹24.13 | ₹9.00 | ₹9.67 | ₹8.40 | ₹8.26 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2019BSE balance sheet (this exchange's own filing had none for this period) | Mar 2020BSE balance sheet (this exchange's own filing had none for this period) | Mar 2025 | TTM |
|---|---|---|---|---|
| Sales | 846 Cr | 993 Cr | 1,572 Cr | Sign in for TTM |
| Operating expenses (approx.) | 682 Cr | 736 Cr | 1,281 Cr | Sign in for TTM |
| EBITDA | 164 Cr | 257 Cr | 291 Cr | Sign in for TTM |
| OPM % | 19.4% | 25.9% | 18.5% | Sign in for TTM |
| Other income | 2 Cr | 6 Cr | 30 Cr | Sign in for TTM |
| Interest | 15 Cr | 10 Cr | 1 Cr | Sign in for TTM |
| Depreciation | 23 Cr | 27 Cr | 71 Cr | Sign in for TTM |
| Profit before tax | 133 Cr | 246 Cr | 249 Cr | Sign in for TTM |
| Tax % | 35.0% | 18.1% | 25.1% | Sign in for TTM |
| Net profit | 86 Cr | 201 Cr | 186 Cr | Sign in for TTM |
| EPS (₹) | ₹40.26 | ₹98.71 | ₹36.40 | Sign in for TTM |
| Dividend payout % | — | — | 27.5% | Sign in for TTM |
Trailing twelve months totals and margin rows
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2019BSE balance sheet (this exchange's own filing had none for this period) | Mar 2020BSE balance sheet (this exchange's own filing had none for this period) | Mar 2025 |
|---|---|---|---|
| Equity capital | 10 Cr | 10 Cr | 10 Cr |
| Reserves | 369 Cr | 526 Cr | 1,392 Cr |
| Borrowings | 128 Cr | 48 Cr | 4 Cr |
| Other liabilities | 255 Cr | 199 Cr | 383 Cr |
| Total liabilities | 763 Cr | 783 Cr | 1,789 Cr |
| Fixed assets (net) | 376 Cr | 422 Cr | 1,041 Cr |
| CWIP | 43 Cr | 45 Cr | 52 Cr |
| Investments | 16 Cr | 0 Cr | 0 Cr |
| Loans & advances | 0.20 Cr | 0.23 Cr | 0.08 Cr |
| Inventories | 106 Cr | 84 Cr | 165 Cr |
| Trade receivables | 153 Cr | 164 Cr | 231 Cr |
| Cash & bank | 19 Cr | 31 Cr | 49 Cr |
| Other assets | 51 Cr | 37 Cr | 251 Cr |
| Total assets | 763 Cr | 783 Cr | 1,789 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2019BSE balance sheet (this exchange's own filing had none for this period) | Mar 2020BSE balance sheet (this exchange's own filing had none for this period) | Mar 2025 |
|---|---|---|---|
| Cash from operating activity | — | — | 263 Cr |
| Cash from investing | — | — | -196 Cr |
| Cash from financing | — | — | -49 Cr |
| Net cash flow | — | — | 18 Cr |
| Free cash flow (OCF − Capex) | — | — | 215 Cr |
Ratios
Ratios as reported or derived per annual period.
| Metric | Mar 2019BSE balance sheet (this exchange's own filing had none for this period) | Mar 2020BSE balance sheet (this exchange's own filing had none for this period) | Mar 2025 |
|---|---|---|---|
| ROCE % | 29.0% | 43.8% | 17.8% |
| ROE % | 0.0% | 44.5% | 13.3% |
| Debtor days | 66 | 60 | 53 |
| Inventory days | 80 | 64 | 72 |
| Days payable | 94 | 54 | 77 |
| Cash conversion cycle | 52 | 70 | 48 |
| Debt / equity | 0.00 | 0.09 | 0.0026 |
| Current ratio | 1.26 | 1.91 | 2.59 |
| Net debt / EBITDA | 0.00 | 0.00 | -0.16 |
Compare with peers
Loading peers…